NFT đang trải qua thời kỳ phục hưng, nhưng liệu người đồng sáng lập Solana có đang dội nước lạnh vào nó không?

Vaxess Technologies

company

About

Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.50M
Industries
Biotechnology,Health Care,Medical
Founded date
Dec 18, 2011
Number Of Employee
1 - 10
Operating Status
Active

Vaxess is commercializing a proprietary technology that uses a silk-derived protein to stabilize vaccines so they can be stored and shipped without refrigeration and a novel sustained release microneedle for improved vaccine delivery. Vaxess strives to not only lower the cost of vaccine distribution, but also increase access to life-saving products for people around the world.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
8
$8.16M
Vaxess Technologies has raised a total of $8.16M in funding over 2 rounds. Their latest funding was raised on Sep 1, 2020 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 1, 2020 Grant $256K 1 National Science Foundation Detail
Oct 9, 2018 Grant $650K 1 National Science Foundation Detail
Dec 14, 2017 Grant $1.50M 1 Detail
Sep 20, 2016 Grant $1.40M 1 National Science Foundation Detail
Apr 6, 2015 Grant $220K 1 Detail

Investors

Number of Lead Investors
Number of Investors
4
3
Vaxess Technologies is funded by 3 investors. National Science Foundation and Norwich Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
Norwich Ventures Yes Series A
National Institutes of Health Grant